SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,159,392 | +6.0% | 92,059 | +0.2% | 0.03% | +13.0% |
| Q2 2023 | $10,526,564 | -14.3% | 91,919 | +3.1% | 0.02% | -17.9% |
| Q1 2023 | $12,284,375 | +6.4% | 89,127 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $11,549,077 | +15.8% | 89,127 | -1.2% | 0.03% | +7.7% |
| Q3 2022 | $9,969,000 | +42.9% | 90,187 | -3.1% | 0.03% | +52.9% |
| Q2 2022 | $6,975,000 | -10.0% | 93,047 | -6.2% | 0.02% | +13.3% |
| Q1 2022 | $7,746,000 | -13.2% | 99,156 | -0.0% | 0.02% | -6.2% |
| Q4 2021 | $8,929,000 | -2.9% | 99,159 | -0.2% | 0.02% | -11.1% |
| Q3 2021 | $9,192,000 | +17.1% | 99,399 | -1.6% | 0.02% | +20.0% |
| Q2 2021 | $7,851,000 | +2.7% | 100,993 | -1.5% | 0.02% | 0.0% |
| Q1 2021 | $7,642,000 | -57.2% | 102,537 | -2.1% | 0.02% | -58.3% |
| Q4 2020 | $17,860,000 | +26.3% | 104,757 | +4.0% | 0.04% | +12.5% |
| Q3 2020 | $14,142,000 | -11.8% | 100,702 | +0.7% | 0.03% | -20.0% |
| Q2 2020 | $16,033,000 | +68.5% | 99,992 | +2.8% | 0.04% | +37.9% |
| Q1 2020 | $9,514,000 | -23.9% | 97,265 | +0.4% | 0.03% | -6.5% |
| Q4 2019 | $12,505,000 | +69.9% | 96,911 | -0.9% | 0.03% | +63.2% |
| Q3 2019 | $7,362,000 | -48.5% | 97,748 | +3.9% | 0.02% | -48.6% |
| Q2 2019 | $14,296,000 | +37.9% | 94,086 | +8.2% | 0.04% | +32.1% |
| Q1 2019 | $10,368,000 | +10.8% | 86,986 | +1.4% | 0.03% | 0.0% |
| Q4 2018 | $9,359,000 | -28.1% | 85,756 | +6.4% | 0.03% | -15.2% |
| Q3 2018 | $13,014,000 | +18.9% | 80,580 | -2.7% | 0.03% | +13.8% |
| Q2 2018 | $10,944,000 | +333.9% | 82,793 | +143.3% | 0.03% | +314.3% |
| Q1 2018 | $2,522,000 | +35.2% | 34,033 | +1.5% | 0.01% | +40.0% |
| Q4 2017 | $1,866,000 | +39.3% | 33,539 | +13.5% | 0.01% | +25.0% |
| Q3 2017 | $1,340,000 | +34.5% | 29,549 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $996,000 | +24.8% | 29,549 | +9.5% | 0.00% | +50.0% |
| Q1 2017 | $798,000 | +7.8% | 26,975 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $740,000 | -58.0% | 26,975 | -6.1% | 0.00% | -60.0% |
| Q3 2016 | $1,764,000 | +179.1% | 28,725 | -13.3% | 0.01% | +150.0% |
| Q2 2016 | $632,000 | -8.8% | 33,135 | -6.7% | 0.00% | -33.3% |
| Q1 2016 | $693,000 | -49.4% | 35,497 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $1,369,000 | +1.3% | 35,497 | -15.6% | 0.01% | 0.0% |
| Q3 2015 | $1,351,000 | +5.5% | 42,082 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $1,281,000 | +152.7% | 42,082 | +10.3% | 0.01% | +150.0% |
| Q1 2015 | $507,000 | -11.5% | 38,145 | -3.7% | 0.00% | 0.0% |
| Q4 2014 | $573,000 | -30.5% | 39,624 | +1.4% | 0.00% | -33.3% |
| Q3 2014 | $824,000 | -29.9% | 39,074 | -0.9% | 0.00% | -25.0% |
| Q2 2014 | $1,175,000 | +36.0% | 39,434 | +9.7% | 0.00% | +33.3% |
| Q1 2014 | $864,000 | +17.9% | 35,962 | 0.0% | 0.00% | +50.0% |
| Q4 2013 | $733,000 | -57.0% | 35,962 | -0.4% | 0.00% | -66.7% |
| Q3 2013 | $1,706,000 | +24.7% | 36,122 | +0.5% | 0.01% | +20.0% |
| Q2 2013 | $1,368,000 | – | 35,942 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |